Search research articles
Contact Us
Filters
Showing results (101-110 of 156) with videos related to
Page
of 16
Sort By:
Advances in Experimental Medicine and Biology
|
January 1, 1986
The multiplicity of the D1 dopamine receptor
R B Mailman, D W Schulz, C D Kilts, et al.
Brain Research
|
October 29, 1984
AF64A, a cholinergic neurotoxin, selectively depletes acetylcholine in hippocampus and cortex, and produces long-term passive avoidance and radial-arm maze deficits in the rat
T J Walsh, H A Tilson, D L DeHaven, et al.
European Journal of Pharmacology
|
May 18, 1984
SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions
R B Mailman, D W Schulz, M H Lewis, et al.
Synapse (New York, N.Y.)
|
February 13, 2001
Quantification of D1B(D5) receptors in dopamine D1A receptor-deficient mice
D M Montague, C D Striplin, J S Overcash, et al.
Journal of Medicinal Chemistry
|
July 22, 1994
Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist
T A Knoerzer, D E Nichols, W K Brewster, et al.
Journal of Medicinal Chemistry
|
August 28, 1999
Quantitative structure-activity relationship modeling of dopamine D(1) antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods
B Hoffman, S J Cho, W Zheng, et al.
Journal of Medicinal Chemistry
|
January 20, 1995
Evaluation of cis- and trans-9- and 11-hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridines as structurally rigid, selective D1 dopamine receptor ligands
W K Brewster, D E Nichols, V J Watts, et al.
European Journal of Pharmacology
|
February 18, 1986
Motor effects of calcitonin administered intracerebroventricularly in the rat
M J Twery, B Kirkpatrick, E C Critcher, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1986
SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons
T C Napier, B S Givens, D W Schulz, et al.
Neuropharmacology
|
May 1, 1995
"Full" dopamine D1 agonists in human caudate: biochemical properties and therapeutic implications
J H Gilmore, V J Watts, C P Lawler, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 156) with videos related to
Sort By:
Page
of 16
Advances in Experimental Medicine and Biology
|
January 1, 1986
The multiplicity of the D1 dopamine receptor
R B Mailman, D W Schulz, C D Kilts, et al.
Brain Research
|
October 29, 1984
AF64A, a cholinergic neurotoxin, selectively depletes acetylcholine in hippocampus and cortex, and produces long-term passive avoidance and radial-arm maze deficits in the rat
T J Walsh, H A Tilson, D L DeHaven, et al.
European Journal of Pharmacology
|
May 18, 1984
SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions
R B Mailman, D W Schulz, M H Lewis, et al.
Synapse (New York, N.Y.)
|
February 13, 2001
Quantification of D1B(D5) receptors in dopamine D1A receptor-deficient mice
D M Montague, C D Striplin, J S Overcash, et al.
Journal of Medicinal Chemistry
|
July 22, 1994
Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist
T A Knoerzer, D E Nichols, W K Brewster, et al.
Journal of Medicinal Chemistry
|
August 28, 1999
Quantitative structure-activity relationship modeling of dopamine D(1) antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods
B Hoffman, S J Cho, W Zheng, et al.
Journal of Medicinal Chemistry
|
January 20, 1995
Evaluation of cis- and trans-9- and 11-hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridines as structurally rigid, selective D1 dopamine receptor ligands
W K Brewster, D E Nichols, V J Watts, et al.
European Journal of Pharmacology
|
February 18, 1986
Motor effects of calcitonin administered intracerebroventricularly in the rat
M J Twery, B Kirkpatrick, E C Critcher, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1986
SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons
T C Napier, B S Givens, D W Schulz, et al.
Neuropharmacology
|
May 1, 1995
"Full" dopamine D1 agonists in human caudate: biochemical properties and therapeutic implications
J H Gilmore, V J Watts, C P Lawler, et al.
Page
of 16